358 GENES FOUNDi
Show / hide columns Aggregate: Custom reports Download: XML | RDF | TSV | JSON | Custom TSV/JSON Page of 8 | next »
Genei
Gene descriptioni x
Evidencei x
Tissuei
Braini
Single celli
Subcelli
Canceri
Bloodi
Cell linei
Struct & Inti
Prognostic p-valuei x
FIBINFin bud initiation factor homolog
Thyroid Carcinoma (TCGA): 9.42e-6
Kidney Renal Clear Cell Carcinoma (TCGA): 1.71e-5
Kidney Renal Papillary Cell Carcinoma (TCGA): 8.68e-5
Ovary Serous Cystadenocarcinoma (TCGA): 1.97e-4
Stomach Adenocarcinoma (TCGA): 2.50e-4
Pancreatic Adenocarcinoma (validation): 2.52e-4
Bladder Urothelial Carcinoma (TCGA): 4.08e-4
Ovary Serous Cystadenocarcinoma (validation): 8.02e-4
Kidney Chromophobe (TCGA): 9.17e-4
TRMT10ATRNA methyltransferase 10A
Thyroid Carcinoma (TCGA): 2.95e-5
Kidney Renal Clear Cell Carcinoma (TCGA): 7.54e-5
Lung Adenocarcinoma (TCGA): 2.54e-4
Kidney Renal Clear Cell Carcinoma (validation): 4.20e-4
MFAP3LMicrofibril associated protein 3 like
Kidney Renal Clear Cell Carcinoma (TCGA): 6.12e-9
Thyroid Carcinoma (TCGA): 3.38e-5
Kidney Renal Clear Cell Carcinoma (validation): 1.37e-4
Kidney Renal Papillary Cell Carcinoma (TCGA): 3.23e-4
Stomach Adenocarcinoma (TCGA): 4.53e-4
BAG2BAG cochaperone 2
Liver Hepatocellular Carcinoma (validation): 1.25e-6
Liver Hepatocellular Carcinoma (TCGA): 4.74e-6
Thyroid Carcinoma (TCGA): 4.65e-5
Skin Cuteneous Melanoma (TCGA): 5.18e-4
Kidney Renal Clear Cell Carcinoma (TCGA): 5.38e-4
Lung Adenocarcinoma (TCGA): 8.72e-4
MOB3BMOB kinase activator 3B
Kidney Renal Clear Cell Carcinoma (TCGA): 1.53e-12
Thyroid Carcinoma (TCGA): 6.02e-5
Kidney Renal Clear Cell Carcinoma (validation): 1.90e-4
SYNCSyncoilin, intermediate filament protein
Liver Hepatocellular Carcinoma (TCGA): 5.01e-5
Thyroid Carcinoma (TCGA): 9.72e-5
Glioblastoma Multiforme (validation): 2.10e-4
Liver Hepatocellular Carcinoma (validation): 5.06e-4
GFPT2Glutamine-fructose-6-phosphate transaminase 2
Kidney Renal Clear Cell Carcinoma (TCGA): 2.89e-8
Thyroid Carcinoma (TCGA): 1.14e-4
Kidney Renal Clear Cell Carcinoma (validation): 6.06e-4
Lung Adenocarcinoma (validation): 6.82e-4
Head and Neck Squamous Cell Carcinoma (TCGA): 9.95e-4
SLC39A7Solute carrier family 39 member 7
Kidney Renal Clear Cell Carcinoma (TCGA): 1.99e-6
Liver Hepatocellular Carcinoma (validation): 1.08e-5
Thyroid Carcinoma (TCGA): 1.15e-4
Liver Hepatocellular Carcinoma (TCGA): 8.02e-4
JHYJunctional cadherin complex regulator
Rectum Adenocarcinoma (validation): 3.82e-5
Glioblastoma Multiforme (TCGA): 6.19e-5
Glioblastoma Multiforme (validation): 7.10e-5
Lung Squamous Cell Carcinoma (TCGA): 8.08e-5
Thyroid Carcinoma (TCGA): 1.31e-4
Kidney Renal Clear Cell Carcinoma (TCGA): 6.07e-4
ZBTB21Zinc finger and BTB domain containing 21
Kidney Renal Clear Cell Carcinoma (TCGA): 1.38e-4
Thyroid Carcinoma (TCGA): 1.41e-4
Kidney Renal Clear Cell Carcinoma (validation): 6.53e-4
ZNF331Zinc finger protein 331
Kidney Renal Clear Cell Carcinoma (TCGA): 1.85e-4
Thyroid Carcinoma (TCGA): 2.32e-4
Kidney Renal Clear Cell Carcinoma (validation): 4.21e-4
Lung Squamous Cell Carcinoma (TCGA): 7.59e-4
Kidney Renal Papillary Cell Carcinoma (TCGA): 9.25e-4
CPPED1Calcineurin like phosphoesterase domain containing 1
Kidney Renal Clear Cell Carcinoma (TCGA): 2.74e-9
Breast Invasive Carcinoma (TCGA): 5.61e-5
Glioblastoma Multiforme (TCGA): 9.43e-5
Thyroid Carcinoma (TCGA): 3.61e-4
Glioblastoma Multiforme (validation): 8.73e-4
ELNElastin
Kidney Renal Papillary Cell Carcinoma (TCGA): 1.99e-8
Kidney Renal Clear Cell Carcinoma (validation): 1.73e-4
Kidney Renal Clear Cell Carcinoma (TCGA): 2.38e-4
Thyroid Carcinoma (TCGA): 3.96e-4
TPD52L2TPD52 like 2
Liver Hepatocellular Carcinoma (TCGA): 5.28e-8
Liver Hepatocellular Carcinoma (validation): 1.05e-5
Thyroid Carcinoma (TCGA): 4.02e-4
Breast Invasive Carcinoma (TCGA): 4.16e-4
Kidney Renal Clear Cell Carcinoma (TCGA): 7.37e-4
SLC2A9Solute carrier family 2 member 9
Kidney Renal Clear Cell Carcinoma (TCGA): 4.04e-11
Thyroid Carcinoma (TCGA): 4.11e-4
Ovary Serous Cystadenocarcinoma (TCGA): 6.84e-4
Kidney Renal Clear Cell Carcinoma (validation): 7.50e-4
TRMT9BTRNA methyltransferase 9B (putative)
Kidney Renal Clear Cell Carcinoma (validation): 1.48e-4
Kidney Renal Clear Cell Carcinoma (TCGA): 1.68e-4
Kidney Renal Papillary Cell Carcinoma (TCGA): 4.57e-4
Thyroid Carcinoma (TCGA): 5.52e-4
CKLFChemokine like factor
Liver Hepatocellular Carcinoma (TCGA): 1.65e-8
Liver Hepatocellular Carcinoma (validation): 5.46e-5
Thyroid Carcinoma (TCGA): 5.54e-4
Pancreatic Adenocarcinoma (TCGA): 8.25e-4
Lung Adenocarcinoma (validation): 8.63e-4
SLC2A8Solute carrier family 2 member 8
Kidney Renal Clear Cell Carcinoma (TCGA): 1.07e-6
Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma (TCGA): 1.00e-5
Pancreatic Adenocarcinoma (TCGA): 2.84e-5
Pancreatic Adenocarcinoma (validation): 2.94e-4
Thyroid Carcinoma (TCGA): 5.81e-4
Kidney Renal Papillary Cell Carcinoma (TCGA): 6.84e-4
ERP29Endoplasmic reticulum protein 29
Liver Hepatocellular Carcinoma (TCGA): 1.08e-5
Liver Hepatocellular Carcinoma (validation): 4.73e-5
Thyroid Carcinoma (TCGA): 7.34e-4
STOX2Storkhead box 2
Kidney Renal Clear Cell Carcinoma (validation): 9.26e-5
Kidney Renal Clear Cell Carcinoma (TCGA): 4.90e-4
Thyroid Carcinoma (TCGA): 7.85e-4
GMPSGuanine monophosphate synthase
Liver Hepatocellular Carcinoma (validation): 2.29e-7
Liver Hepatocellular Carcinoma (TCGA): 6.63e-7
Pancreatic Adenocarcinoma (TCGA): 1.80e-6
Lung Adenocarcinoma (TCGA): 3.44e-5
Lung Adenocarcinoma (validation): 6.08e-5
Kidney Renal Papillary Cell Carcinoma (TCGA): 4.65e-4
Thyroid Carcinoma (TCGA): 8.47e-4
C1orf53Chromosome 1 open reading frame 53
Kidney Renal Clear Cell Carcinoma (TCGA): 2.28e-8
Kidney Renal Clear Cell Carcinoma (validation): 3.77e-6
Thyroid Carcinoma (TCGA): 8.70e-4
PTGR3Prostaglandin reductase 3
Kidney Renal Clear Cell Carcinoma (TCGA): 3.25e-6
Kidney Renal Clear Cell Carcinoma (validation): 1.78e-4
Thyroid Carcinoma (TCGA): 8.95e-4
CLTAClathrin light chain A
Kidney Renal Clear Cell Carcinoma (TCGA): 5.64e-7
Liver Hepatocellular Carcinoma (TCGA): 7.28e-6
Liver Hepatocellular Carcinoma (validation): 5.70e-5
Thyroid Carcinoma (TCGA): 9.04e-4
NXT1Nuclear transport factor 2 like export factor 1
Liver Hepatocellular Carcinoma (TCGA): 3.41e-5
Liver Hepatocellular Carcinoma (validation): 7.72e-4
Thyroid Carcinoma (TCGA): 9.23e-4
SYNDIG1Synapse differentiation inducing 1
Thyroid Carcinoma (TCGA): 4.13e-7
RAC3Rac family small GTPase 3
Thyroid Carcinoma (TCGA): 5.75e-7
Kidney Renal Clear Cell Carcinoma (TCGA): 3.93e-5
Ovary Serous Cystadenocarcinoma (validation): 6.22e-4
ROR2Receptor tyrosine kinase like orphan receptor 2
Thyroid Carcinoma (TCGA): 1.06e-6
SNAI1Snail family transcriptional repressor 1
Thyroid Carcinoma (TCGA): 1.22e-6
Skin Cuteneous Melanoma (TCGA): 2.01e-5
Lung Squamous Cell Carcinoma (TCGA): 4.23e-4
Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma (TCGA): 7.26e-4
UCHL5Ubiquitin C-terminal hydrolase L5
Thyroid Carcinoma (TCGA): 1.51e-6
Kidney Renal Clear Cell Carcinoma (TCGA): 1.73e-5
Pancreatic Adenocarcinoma (TCGA): 1.38e-4
Skin Cuteneous Melanoma (TCGA): 6.96e-4
FADS1Fatty acid desaturase 1
Thyroid Carcinoma (TCGA): 1.91e-6
ALDH1B1Aldehyde dehydrogenase 1 family member B1
Thyroid Carcinoma (TCGA): 1.99e-6
Kidney Renal Clear Cell Carcinoma (TCGA): 1.45e-5
Pancreatic Adenocarcinoma (validation): 1.71e-4
Lung Adenocarcinoma (validation): 1.93e-4
Ovary Serous Cystadenocarcinoma (TCGA): 8.71e-4
PDLIM3PDZ and LIM domain 3
Thyroid Carcinoma (TCGA): 2.26e-6
Stomach Adenocarcinoma (TCGA): 6.09e-4
UNC119Unc-119 lipid binding chaperone
Thyroid Carcinoma (TCGA): 2.38e-6
Glioblastoma Multiforme (TCGA): 3.58e-5
Kidney Renal Clear Cell Carcinoma (TCGA): 7.63e-5
Kidney Renal Clear Cell Carcinoma (validation): 1.08e-4
TRIM21Tripartite motif containing 21
Liver Hepatocellular Carcinoma (TCGA): 4.73e-7
Thyroid Carcinoma (TCGA): 2.64e-6
Kidney Renal Clear Cell Carcinoma (TCGA): 1.61e-5
Liver Hepatocellular Carcinoma (validation): 4.03e-4
TMEM120BTransmembrane protein 120B
Thyroid Carcinoma (TCGA): 3.33e-6
Liver Hepatocellular Carcinoma (TCGA): 1.88e-5
SUGCTSuccinyl-CoA:glutarate-CoA transferase
Kidney Renal Clear Cell Carcinoma (TCGA): 2.47e-12
Thyroid Carcinoma (TCGA): 6.13e-6
Liver Hepatocellular Carcinoma (TCGA): 2.44e-4
Kidney Renal Clear Cell Carcinoma (validation): 4.29e-4
ENDOVEndonuclease V
Thyroid Carcinoma (TCGA): 6.46e-6
Lung Adenocarcinoma (TCGA): 6.80e-4
KLK12Kallikrein related peptidase 12
Thyroid Carcinoma (TCGA): 1.23e-5
Lung Adenocarcinoma (TCGA): 6.97e-4
WDR37WD repeat domain 37
Glioblastoma Multiforme (validation): 4.73e-6
Thyroid Carcinoma (TCGA): 1.32e-5
Pancreatic Adenocarcinoma (TCGA): 1.03e-4
Head and Neck Squamous Cell Carcinoma (TCGA): 1.10e-4
Kidney Renal Papillary Cell Carcinoma (TCGA): 1.27e-4
Kidney Renal Clear Cell Carcinoma (TCGA): 1.32e-4
HPGD15-hydroxyprostaglandin dehydrogenase
Kidney Renal Clear Cell Carcinoma (TCGA): 2.39e-7
Thyroid Carcinoma (TCGA): 1.33e-5
NINJ1Ninjurin 1
Thyroid Carcinoma (TCGA): 1.36e-5
SEMA6BSemaphorin 6B
Thyroid Carcinoma (TCGA): 1.39e-5
Kidney Renal Papillary Cell Carcinoma (TCGA): 1.38e-4
MRS2Magnesium transporter MRS2
Thyroid Carcinoma (TCGA): 1.41e-5
Kidney Renal Clear Cell Carcinoma (TCGA): 1.49e-5
Ovary Serous Cystadenocarcinoma (TCGA): 1.55e-4
CILPCartilage intermediate layer protein
Thyroid Carcinoma (TCGA): 1.52e-5
PNMA2PNMA family member 2
Thyroid Carcinoma (TCGA): 1.73e-5
Kidney Renal Clear Cell Carcinoma (TCGA): 2.77e-5
Lung Adenocarcinoma (TCGA): 1.91e-4
GAS1Growth arrest specific 1
Thyroid Carcinoma (TCGA): 1.81e-5
Ovary Serous Cystadenocarcinoma (TCGA): 7.16e-5
Rectum Adenocarcinoma (TCGA): 1.18e-4
Stomach Adenocarcinoma (TCGA): 9.68e-4
DNAAF8Dynein axonemal assembly factor 8
Thyroid Carcinoma (TCGA): 2.47e-5
TSHZ2Teashirt zinc finger homeobox 2
Thyroid Carcinoma (TCGA): 2.60e-5
Glioblastoma Multiforme (TCGA): 2.21e-4
Lung Adenocarcinoma (validation): 4.36e-4
Glioblastoma Multiforme (validation): 7.86e-4
Ovary Serous Cystadenocarcinoma (validation): 8.56e-4
Page of 8 | next »